{"id":"https://openalex.org/W7223696771","doi":"https://doi.org/10.53941/ti.2026.100025","title":"Profound Radiographic and Tumor-Lytic Response of Locally Advanced Pancreatic Adenocarcinoma to a Non-Systemic-Chemotherapy Multimodal Protocol\u2014Fractionated Radiotherapy with Capecitabine Radiosensitization, Intratumoral EpCAM/CD3 Bispecific Antibody, Allogeneic NK and Autologous Lymphocyte Cellular Therapy, and Sequenced Pembrolizumab Following Failure of Conventional Gemcitabine-Based Therapy","display_name":"Profound Radiographic and Tumor-Lytic Response of Locally Advanced Pancreatic Adenocarcinoma to a Non-Systemic-Chemotherapy Multimodal Protocol\u2014Fractionated Radiotherapy with Capecitabine Radiosensitization, Intratumoral EpCAM/CD3 Bispecific Antibody, Allogeneic NK and Autologous Lymphocyte Cellular Therapy, and Sequenced Pembrolizumab Following Failure of Conventional Gemcitabine-Based Therapy","publication_year":2026,"publication_date":"2026-10-26","ids":{"openalex":"https://openalex.org/W7223696771","doi":"https://doi.org/10.53941/ti.2026.100025"},"language":"en","primary_location":{"id":"doi:10.53941/ti.2026.100025","doi":"https://doi.org/10.53941/ti.2026.100025","is_oa":true,"landing_page_url":"https://doi.org/10.53941/ti.2026.100025","pdf_url":"https://media.sciltp.com/articles/2608004959/2608004959.pdf","source":{"id":"https://openalex.org/S7407057919","display_name":"Translational Insights","issn_l":"3083-2276","issn":["3083-2276"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Insights","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://media.sciltp.com/articles/2608004959/2608004959.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159621183","display_name":"Heberto Scharamm","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heberto Scharamm","raw_affiliation_strings":["Department of Integrative Oncology, Hesieg Hospital and ICCA CancerCare, Tijuana 22329, Baja California, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Integrative Oncology, Hesieg Hospital and ICCA CancerCare, Tijuana 22329, Baja California, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159703138","display_name":"Ricardo Ramos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ricardo Ramos","raw_affiliation_strings":["Department of Integrative Oncology, Hesieg Hospital and ICCA CancerCare, Tijuana 22329, Baja California, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Integrative Oncology, Hesieg Hospital and ICCA CancerCare, Tijuana 22329, Baja California, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003775442","display_name":"Alfredo Medina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alfredo Medina","raw_affiliation_strings":["Department of Integrative Oncology, Hesieg Hospital and ICCA CancerCare, Tijuana 22329, Baja California, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Integrative Oncology, Hesieg Hospital and ICCA CancerCare, Tijuana 22329, Baja California, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159588080","display_name":"Yi Ma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi Ma","raw_affiliation_strings":["Department of Integrative Oncology, Hesieg Hospital and ICCA CancerCare, Tijuana 22329, Baja California, Mexico","ICCA Inc., Dana Point, CA 92629, USA, and American Center for Organ Restoration (ACOR Inc.), Dana Point, CA 92629, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Integrative Oncology, Hesieg Hospital and ICCA CancerCare, Tijuana 22329, Baja California, Mexico","institution_ids":[]},{"raw_affiliation_string":"ICCA Inc., Dana Point, CA 92629, USA, and American Center for Organ Restoration (ACOR Inc.), Dana Point, CA 92629, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049862554","display_name":"Siegmund Schramm","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Siegmund Schramm","raw_affiliation_strings":["Department of Integrative Oncology, Hesieg Hospital and ICCA CancerCare, Tijuana 22329, Baja California, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Integrative Oncology, Hesieg Hospital and ICCA CancerCare, Tijuana 22329, Baja California, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5141080594","display_name":"Thomas Ichim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Ichim","raw_affiliation_strings":["ICCA Inc., Dana Point, CA 92629, USA, and American Center for Organ Restoration (ACOR Inc.), Dana Point, CA 92629, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICCA Inc., Dana Point, CA 92629, USA, and American Center for Organ Restoration (ACOR Inc.), Dana Point, CA 92629, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082367491","display_name":"Greg DiRienzo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Greg DiRienzo","raw_affiliation_strings":["ICCA Inc., Dana Point, CA 92629, USA, and American Center for Organ Restoration (ACOR Inc.), Dana Point, CA 92629, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICCA Inc., Dana Point, CA 92629, USA, and American Center for Organ Restoration (ACOR Inc.), Dana Point, CA 92629, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.80748765,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"1","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/locally-advanced-pancreatic-adenocarcinoma","display_name":"locally advanced pancreatic adenocarcinoma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/fractionated-radiotherapy","display_name":"fractionated radiotherapy","score":0.972000002861023},{"id":"https://openalex.org/keywords/intratumoral-injection","display_name":"intratumoral injection","score":0.8889999985694885},{"id":"https://openalex.org/keywords/allogeneic-nk-cell-therapy","display_name":"allogeneic NK cell therapy","score":0.8510000109672546},{"id":"https://openalex.org/keywords/allogeneic-mesenchymal-stromal-cells","display_name":"allogeneic mesenchymal stromal cells","score":0.9120000004768372},{"id":"https://openalex.org/keywords/high-dose-vitamin-c","display_name":"high-dose vitamin C","score":0.8830000162124634},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9879999756813049},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6340000033378601},{"id":"https://openalex.org/keywords/multimodal-treatment","display_name":"multimodal therapy","score":0.5049999952316284},{"id":"https://openalex.org/keywords/gemcitabine-refractory-disease","display_name":"gemcitabine-refractory disease","score":0.7300000190734863},{"id":"https://openalex.org/keywords/tumor-cell-lysis","display_name":"tumor cell lysis","score":0.6269999742507935},{"id":"https://openalex.org/keywords/bile-duct-involvement","display_name":"bile duct involvement","score":0.5339999794960022}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9433000087738037},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.795799970626831},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.6340000033378601},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.5412999987602234},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.49309998750686646},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4625000059604645},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44929999113082886},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.4205999970436096},{"id":"https://openalex.org/C2778764654","wikidata":"https://www.wikidata.org/wiki/Q9618","display_name":"Pancreas","level":2,"score":0.38909998536109924},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36739999055862427},{"id":"https://openalex.org/C2779777945","wikidata":"https://www.wikidata.org/wiki/Q851111","display_name":"Bile duct","level":2,"score":0.36640000343322754},{"id":"https://openalex.org/C2778975757","wikidata":"https://www.wikidata.org/wiki/Q1266423","display_name":"Pancreaticoduodenectomy","level":3,"score":0.36010000109672546},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.34360000491142273},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.3346000015735626},{"id":"https://openalex.org/C2776737053","wikidata":"https://www.wikidata.org/wiki/Q7130407","display_name":"Pancreatic disease","level":3,"score":0.33379998803138733},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.32899999618530273},{"id":"https://openalex.org/C2779960720","wikidata":"https://www.wikidata.org/wiki/Q668063","display_name":"Pancreatic duct","level":3,"score":0.3240000009536743},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2985999882221222},{"id":"https://openalex.org/C2777148230","wikidata":"https://www.wikidata.org/wiki/Q17144959","display_name":"FOLFIRINOX","level":5,"score":0.2930000126361847},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.29249998927116394},{"id":"https://openalex.org/C2777996000","wikidata":"https://www.wikidata.org/wiki/Q7130412","display_name":"Pancreatic tumor","level":4,"score":0.29190000891685486},{"id":"https://openalex.org/C2780037786","wikidata":"https://www.wikidata.org/wiki/Q3357479","display_name":"Osteoradionecrosis","level":3,"score":0.2874999940395355},{"id":"https://openalex.org/C2775982439","wikidata":"https://www.wikidata.org/wiki/Q3562150","display_name":"Biliary tract","level":2,"score":0.27140000462532043},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.25949999690055847},{"id":"https://openalex.org/C2776670229","wikidata":"https://www.wikidata.org/wiki/Q854573","display_name":"Acute pancreatitis","level":2,"score":0.2572000026702881},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.25099998712539673}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.53941/ti.2026.100025","doi":"https://doi.org/10.53941/ti.2026.100025","is_oa":true,"landing_page_url":"https://doi.org/10.53941/ti.2026.100025","pdf_url":"https://media.sciltp.com/articles/2608004959/2608004959.pdf","source":{"id":"https://openalex.org/S7407057919","display_name":"Translational Insights","issn_l":"3083-2276","issn":["3083-2276"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Insights","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.53941/ti.2026.100025","doi":"https://doi.org/10.53941/ti.2026.100025","is_oa":true,"landing_page_url":"https://doi.org/10.53941/ti.2026.100025","pdf_url":"https://media.sciltp.com/articles/2608004959/2608004959.pdf","source":{"id":"https://openalex.org/S7407057919","display_name":"Translational Insights","issn_l":"3083-2276","issn":["3083-2276"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Insights","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223696771.pdf","grobid_xml":"https://content.openalex.org/works/W7223696771.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1968812902","https://openalex.org/W2037150116","https://openalex.org/W2131170195","https://openalex.org/W2345822778","https://openalex.org/W3014980845","https://openalex.org/W3098332911","https://openalex.org/W3106806530","https://openalex.org/W3116897892","https://openalex.org/W3119097268","https://openalex.org/W3171147818","https://openalex.org/W4220914612","https://openalex.org/W4220963866","https://openalex.org/W4297497831","https://openalex.org/W4323354411","https://openalex.org/W4328048621","https://openalex.org/W4361215749","https://openalex.org/W4379619261","https://openalex.org/W4387436081","https://openalex.org/W4387532718","https://openalex.org/W4389900160","https://openalex.org/W4396240363","https://openalex.org/W4406252950"],"related_works":["https://openalex.org/W4328048131","https://openalex.org/W2540927778","https://openalex.org/W2798389324","https://openalex.org/W2107433011","https://openalex.org/W2269656621","https://openalex.org/W4400697654","https://openalex.org/W2461302831","https://openalex.org/W3124806301","https://openalex.org/W7095881349","https://openalex.org/W4392311672"],"abstract_inverted_index":{"Introduction:":[0],"Locally":[1],"advanced":[2],"pancreatic":[3,70,132,168,418],"adenocarcinoma":[4,71],"(LAPC)":[5],"carries":[6],"a":[7,37,49,94,130,154,290,376,456,515],"dismal":[8],"prognosis":[9],"with":[10,69,153,259,353,387,398,462,496],"conventional":[11,56,452],"therapy.":[12],"Patients":[13],"who":[14],"progress":[15],"on":[16,123,302,324,371],"or":[17,32,422],"plateau":[18],"after":[19,55,310,449],"first-line":[20],"gemcitabine-based":[21],"chemotherapy":[22,52,279,454,485],"have":[23],"limited":[24],"evidence-based":[25],"options":[26],"outside":[27],"of":[28,39,45,58,82,190,206,220,227,242,312,331,335,357,401,451],"further":[29],"cytotoxic":[30,278,484],"regimens":[31],"palliative":[33],"care.":[34],"We":[35],"report":[36],"case":[38,432],"profound":[40,435],"radiographic":[41,399,436],"and":[42,170,199,255,266,333,344,425,472,480,486,501,505],"tumor-lytic":[43,355,508],"response":[44,96],"bulky":[46,131,421,447],"LAPC":[47,448],"to":[48,116,166,381],"multimodal":[50,155,457],"non-systemic":[51],"protocol":[53,156,458],"delivered":[54,323],"standard":[57],"care":[59],"had":[60],"been":[61],"exhausted.":[62],"Case:":[63],"A":[64,317],"56-year-old":[65],"man":[66],"originally":[67],"diagnosed":[68],"involving":[72,134],"the":[73,105,110,135,167,313,337,347,354,392,417,506],"bile":[74,136],"duct":[75,137],"in":[76,163,378,416,446,514],"March":[77,304],"2023":[78],"received":[79,275],"three":[80],"cycles":[81],"gemcitabine":[83,453],"at":[84,280,289],"Mayo":[85],"Clinic":[86],"(Rochester,":[87],"MN).":[88],"His":[89],"August":[90],"2024":[91],"PET/CT":[92,406],"documented":[93,129],"partial":[95],"(pancreatic":[97],"head":[98],"SUV-max":[99],"3.0,":[100],"down":[101],"from":[102],"4.1).":[103],"Over":[104],"subsequent":[106],"17":[107],"months,":[108],"however,":[109],"disease":[111],"progressed":[112],"locoregionally.":[113],"At":[114],"admission":[115],"ICCA":[117,284],"CancerCare":[118],"(Hesieg":[119],"Hospital,":[120],"Tijuana,":[121],"Mexico)":[122],"26":[124,149],"January":[125],"2026,":[126,305],"contrast":[127,369],"CT":[128,370],"mass":[133],"measuring":[138],"101.3":[139],"mm":[140,383,386],"\u00d7":[141,384],"93.68":[142],"mm.":[143],"Intervention:":[144],"The":[145,273,490],"patient":[146,274],"was":[147,287,300,322],"treated":[148],"January\u20136":[150],"February":[151],"2026":[152,374],"comprising":[157],"(i)":[158],"fractionated":[159,460],"radiotherapy,":[160],"35":[161],"Gy":[162],"10":[164],"sessions":[165],"tumor":[169,338,379,441,498],"adjacent":[171],"lymph":[172],"nodes;":[173],"(ii)":[174],"oral":[175],"capecitabine":[176,286,463],"500":[177,263],"mg":[178,264],"daily":[179],"for":[180,293],"30":[181],"days":[182],"as":[183],"radiosensitization;":[184],"(iii)":[185],"two":[186,217,224,239],"image-guided":[187],"intratumoral":[188,319,465],"injections":[189],"an":[191],"EpCAM/CD3":[192,358,466],"bispecific":[193,359,467],"T-cell-engaging":[194,468],"antibody":[195],"under":[196],"ultrasound":[197],"guidance":[198],"local":[200],"anesthesia;":[201],"(iv)":[202],"four":[203,271],"intravenous":[204,218,225,240,260],"infusions":[205,219,226,241],"allogeneic":[207,228,470,477],"natural-killer":[208],"(NK)":[209],"cells":[210,213,231,235],"(100":[211,297],"million":[212,234],"per":[214,236],"infusion);":[215,237],"(v)":[216],"autologous":[221,473],"lymphocytes;":[222],"(vi)":[223],"mesenchymal":[229],"stromal":[230],"(MSCs,":[232],"50":[233],"(vii)":[238],"high-dose":[243],"vitamin":[244],"C;":[245],"(viii)":[246],"IV":[247,251],"multivitamin/electrolyte":[248],"support;":[249],"(ix)":[250],"esomeprazole":[252],"40":[253],"mg;":[254],"(x)":[256],"anemia":[257],"management":[258],"ferric":[261],"carboxymaltose":[262],"twice":[265],"subcutaneous":[267],"erythropoietin":[268],"2000":[269],"IU":[270],"times.":[272],"no":[276,420,426],"systemic":[277,483],"any":[281],"point":[282],"during":[283],"care;":[285],"administered":[288,301],"sub-cytotoxic":[291],"dose":[292],"radiosensitization":[294],"only.":[295],"Pembrolizumab":[296],"mg/4":[298],"mL)":[299],"18":[303],"sequenced":[306,481],"approximately":[307],"six":[308],"weeks":[309],"completion":[311,330],"loading-phase":[314],"EpCAM":[315,320],"injections.":[316],"third":[318],"injection":[321],"15":[325],"April":[326],"2026.":[327],"Outcome:":[328],"Between":[329],"radiotherapy":[332,363,461],"administration":[334],"pembrolizumab,":[336],"underwent":[339],"clinically":[340,439],"evident":[341,440],"lysis,":[342,442],"liquefying":[343],"draining":[345],"through":[346],"patient\u2019s":[348],"biliary":[349],"catheter\u2014a":[350],"phenomenon":[351],"consistent":[352],"effect":[356],"T-cell":[360,494],"engagement":[361,495],"that":[362,434],"alone":[364],"does":[365],"not":[366],"produce.":[367],"Follow-up":[368],"13":[372],"May":[373,408],"demonstrated":[375,410],"reduction":[377,397],"dimensions":[380],"87":[382],"72.9":[385],"extensive":[388],"necrotic":[389],"areas":[390],"within":[391],"residual":[393,413],"mass\u2014a":[394],"substantial":[395],"volumetric":[396],"evidence":[400],"internal":[402],"necrosis.":[403],"Surveillance":[404],"\u00b9\u2078F-FDG":[405],"(14":[407],"2026)":[409],"only":[411],"mild":[412],"hypermetabolic":[414,423],"activity":[415],"head,":[419],"adenopathy,":[424],"findings":[427],"concerning":[428],"metastasis.":[429],"Conclusions:":[430],"This":[431],"demonstrates":[433],"response,":[437],"including":[438],"can":[443],"be":[444],"achieved":[445],"failure":[450],"using":[455],"combining":[459],"radiosensitization,":[464],"antibody,":[469],"NK":[471],"lymphocyte":[474],"cellular":[475,502],"therapy,":[476],"MSC":[478],"support,":[479],"pembrolizumab\u2014without":[482],"without":[487],"surgical":[488],"resection.":[489],"mechanistic":[491],"framework":[492],"(cancer-stem-cell-targeted":[493],"cold-to-hot":[497],"microenvironment":[499],"remodeling":[500],"immune":[503],"reinforcement)":[504],"observed":[507],"clinical":[509],"course":[510],"warrant":[511],"prospective":[512],"evaluation":[513],"registry":[516],"cohort.":[517]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-27T00:00:00"}